Stock Price
146.76
Daily Change
0.74 0.51%
Monthly
-18.55%
Yearly
-43.68%
Q1 Forecast
150.05

CSL reported $1.79B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
aTyr Pharma USD 22.13M 6.75M Sep/2025
Cara Therapeutics USD 0 0 Mar/2025
CSL USD 1.79B 2.15B Jun/2025
Curis USD 10.27M 610K Jun/2024
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Infinity Pharmaceuticals USD 352K 89K Jun/2023
Minerva Neurosciences 386K 31K Jun/2024
Sangamo BioSciences 2.42M 1.11M Jun/2024
TherapeuticsMD USD -11.99M 12.34M Dec/2022